GL Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 70 years.
We develop and manufacture both branded and complex generic medicines to help healthcare professionals across the world manage a broad range of conditions.
GL Pharma UK was established in 2021 to support the NHS in providing high quality healthcare to its patients in the most affordable way.
Our products can be found in more than 50 markets worldwide. GL Pharma has 16 distribution structures in Europe and a subsidiary in Central America.
~1.100 employees
~€247 M. (2022) revenue, €363 M. (2022) including Genericon Pharma
~4.670 M. single doses